Neogen Corp (NEOG)
12.41
+0.27
(+2.22%)
USD |
NASDAQ |
May 07, 16:00
12.41
0.00 (0.00%)
After-Hours: 18:31
Neogen Cash from Operations (TTM): 99.48M for Feb. 29, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
February 29, 2024 | 99.48M |
November 30, 2023 | 112.62M |
August 31, 2023 | 78.18M |
May 31, 2023 | 41.03M |
February 28, 2023 | -29.55M |
November 30, 2022 | -5.888M |
August 31, 2022 | 30.68M |
May 31, 2022 | 68.04M |
February 28, 2022 | 69.62M |
November 30, 2021 | 74.62M |
August 31, 2021 | 79.16M |
May 31, 2021 | 81.09M |
February 28, 2021 | 84.75M |
November 30, 2020 | 92.93M |
August 31, 2020 | 87.29M |
May 31, 2020 | 85.88M |
February 29, 2020 | 81.13M |
November 30, 2019 | 71.73M |
August 31, 2019 | 71.48M |
May 31, 2019 | 63.84M |
February 28, 2019 | 65.52M |
November 30, 2018 | 74.31M |
August 31, 2018 | 66.54M |
May 31, 2018 | 69.13M |
February 28, 2018 | 61.66M |
Date | Value |
---|---|
November 30, 2017 | 58.13M |
August 31, 2017 | 58.67M |
May 31, 2017 | 60.27M |
February 28, 2017 | 52.51M |
November 30, 2016 | 44.02M |
August 31, 2016 | 49.01M |
May 31, 2016 | 35.33M |
February 29, 2016 | 38.33M |
November 30, 2015 | 41.29M |
August 31, 2015 | 39.97M |
May 31, 2015 | 43.79M |
February 28, 2015 | 37.98M |
November 30, 2014 | 34.31M |
August 31, 2014 | 26.58M |
May 31, 2014 | 21.67M |
February 28, 2014 | 23.84M |
November 30, 2013 | 25.96M |
August 31, 2013 | 27.62M |
May 31, 2013 | 26.56M |
February 28, 2013 | 28.93M |
November 30, 2012 | 27.44M |
August 31, 2012 | 25.37M |
May 31, 2012 | 22.28M |
February 29, 2012 | 18.12M |
November 30, 2011 | 15.46M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-29.55M
Minimum
Feb 2023
112.62M
Maximum
Nov 2023
66.91M
Average
76.40M
Median
Cash from Operations (TTM) Benchmarks
Moderna Inc | -2.882B |
Regeneron Pharmaceuticals Inc | 4.739B |
Syros Pharmaceuticals Inc | -109.71M |
Disc Medicine Inc | -73.46M |
Amylyx Pharmaceuticals Inc | 11.92M |